CRYOPORT INC
CYRXNASDAQTrading Snapshot
- Day Range
- $17.10 β $17.39
- 52-Week Range
- $7.61 β $17.98
- Volume
- $2.72B
- Avg Volume
- $2.62B
- Shares Outstanding
- 50.4M
- Next Earnings
- Nov 17, 2026
Fundamentals Snapshot
- Annual Revenue
- $176M
- Last Q Revenue
- $49M
- P/E Ratio
- -21.2
- P/S Ratio
- 4.7x
- EPS (TTM)
- $-0.72
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +0.3%
Why Investors Own CYRX
- βHigh-growth profile β revenue up +12.2% YoY with expanding US Equity exposure.
- βHealthy economics β 47% gross margin and 24% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
CRYOPORT INC
CYRXAbout CRYOPORT INC
Cryoport, Inc. operates as a specialized service provider within the life sciences sector, delivering global temperature-controlled supply chain solutions across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Central to their offerings is Cryoportal, a proprietary cloud-based platform designed to streamline the entire logistics process. This robust system facilitates order processing, generates necessary documentation (including customs paperwork), coordinates courier services, offers real-time shipment tracking and monitoring, aids in issue resolution, and ensures adherence to regulatory compliance standards. To guarantee the integrity of sensitive materials during transit, Cryoport provides CryoPort Express Shippers, engineered to maintain the stability of biological commodities throughout their journey. Furthermore, their SmartPak Condition Monitoring System collects vital environmental data, which is then utilized to produce informative dashboards and essential validation reports for each shipment. Their product range also includes specialized containment solutions such as vacuum insulated aluminum dewars and advanced cryogenic freezer systems. Beyond transportation, the company offers extensive biological specimen management services. These encompass cryopreservation storage and ongoing maintenance, meticulous archiving, continuous monitoring, precise tracking, and efficient receipt and delivery of samples. They also manage the transport of frozen biological specimens to and from client facilities and oversee the inbound and outbound flow of these critical materials. Additionally, Cryoport extends its expertise through comprehensive logistics support and management services, alongside short-term consulting in both logistics and engineering. The company primarily caters to the biopharmaceutical, animal health, and human reproductive medicine industries. Founded in 1999, Cryoport's headquarters are situated in Brentwood, Tennessee.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Price Target
βLatest News & Updates
CRYOPORT INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift CYRX price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
CRYOPORT INC announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.